AU;Current Trials
  • Home
  • Clinical Trials
  • Atopic Dermatitis Study Lower Hutt 75

Atopic Dermatitis (Eczema) Study

Lower Hutt

Do you have moderate to severe eczema (Atopic Dermatitis) despite being on current treatments?

Momentum Clinical Research are conducting a study testing a potential new treatment for eczema. The investigational treatment is designed to help reduce inflammation, relieve itching, and improve skin condition for people whose eczema is not well-controlled with current treatments. 

By participating, you may gain early access to a new treatment, receive regular check-ups, and contribute to important research that may benefit others living with eczema.

Description

What to expect

Study details

Ages

18 years or older

Duration

Approximately 18 weeks, with 9 scheduled in-clinic visits throughout the treatment and follow-up periods

Compensation

Participants will be reimbursed up to $1,800

Eligibility Criteria

You may qualify if you:

  • Are 18 years or older
  • Have moderate to severe eczema/atopic dermatitis for at least 6 
    months
  • Have at least 10 palm sizes of Atopic Dermatitis/Eczema on your 
    body
  • Are currently using a topical or systemic eczema treatment
  • In generally good health

Other criteria apply. A member of our team will check if this study is a good fit for you

Locations

Lower Hutt

Description

Atopic dermatitis, also known as eczema, is a chronic skin condition that causes dry, inflamed, and itchy skin. It often appears as red or irritated patches that can come and go over time, making everyday life uncomfortable and affecting sleep, physical comfort, and confidence.

Flare-ups can be triggered by many things - changes in weather, allergens, stress, certain fabrics, foods, or hormonal shifts. People with eczema tend to have a weakened skin barrier, which means their skin is more sensitive to these types of irritants.

While treatments like steroid creams or other topical therapies are commonly used, they don’t always provide long-lasting relief. That’s why researchers are working to find more effective options that go beyond managing symptoms to help improve long-term skin health and quality of life.


This study is testing a potential new treatment, designed to target key drivers of inflammation in eczema.

Researcher’s hope this treatment may:
• Reduce the severity and frequency of flare-ups
• Relieve itching and skin irritation 
• Improve overall skin health and quality of life

What to expect

Participants will be randomly assigned to receive either:
• The investigational treatment, or
• A placebo

All study medication is taken as two oral tablets twice daily, once at morning, once at night. This is a placebo-controlled study so some participants will receive a non-active investigational medicine and some participants will receive the active investigational medicine.

You will attend regular study visits for health assessments, skin examinations and safety monitoring. Your safety and well-being will be closely monitored by our professional clinical team.

Why join a clinical research study? 
- Gain early access to new potential treatments at no cost
- Contribute to research that could help others with eczema
- Learn to better manage your condition
- Receive health checks and advice from our professional medical team

Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.

Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

New Zealand locations

WellingtonTaurangaHawke's BayKapitiPalmerston NorthLower HuttDunedinPukekohe AucklandPCRN Clinical Trial Sites

Australian locations

Fortitude Valley BrisbaneTaringa BrisbaneWellers Hill BrisbaneSunshine MelbourneDarlinghurst SydneySt Leonards Sydney

2025 © Momentum Clinical Research

Privacy Policy